U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 9151 - 9160 of 9894 results

Status:
Investigational
Source:
USAN:SODIUM AMYLOSULFATE [USAN]
Source URL:

Class:
POLYMER

Status:
Investigational
Source:
USAN:LAURETH 10S [USAN]
Source URL:

Class:
POLYMER

Targets:

Conditions:

Laureth 10S is a vaginal contraceptive drug. This agent is capable to interact with the lipoprotic membrane of spermatozoa.
Status:
Investigational
Source:
NCT03858036: Phase 3 Interventional Not yet recruiting Keratoconus
(2019)
Source URL:

Class:
POLYMER

Status:
Investigational
Source:
USAN:ANOXOMER [USAN]
Source URL:

Class:
POLYMER

Anoxomer (E323) is a food additive. It was designed to allow the introduction of established antioxidants in a non-absorbable manner in order to avoid potential health risk associated with their digestion. Anoxomer is an antioxidant, it protects food from deterioration caused by oxidation. Anoxomer may be safely used as an antioxidant in food at a level of not more than 5,000 parts per million based on fat and oil content of the food.
Status:
Investigational
Source:
USAN:ETIRINOTECAN PEGOL TETRAHYDROCHLORIDE [USAN]
Source URL:

Class:
POLYMER

Status:
Investigational
Source:
NCT00268593: Phase 2 Interventional Completed Prostate Cancer
(2005)
Source URL:

Class:
POLYMER

Status:
Investigational
Source:
INN:diclofenac etalhyaluronate [INN]
Source URL:

Class:
POLYMER

Status:
Investigational
Source:
NCT00543400: Phase 2 Interventional Completed Coronary Artery Disease (CAD)
(2007)
Source URL:

Class:
POLYMER

Status:
Investigational
Source:
NCT02205840: Phase 2/Phase 3 Interventional Completed Dry Eye Syndromes
(2014)
Source URL:

Class:
POLYMER

Status:
Investigational
Source:
NCT00034294: Phase 2 Interventional Completed Clostridium Difficile-Associated Diarrhea
(2002)
Source URL:

Class:
POLYMER

Showing 9151 - 9160 of 9894 results